These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 16225622)

  • 1. Primary cutaneous CD30+ T-cell lymphoproliferative disorder following cardiac transplantation in a 15-year-old boy with Netherton's syndrome.
    Katugampola RP; Finlay AY; Harper JI; Dojcinov S; Maughan TS
    Br J Dermatol; 2005 Nov; 153(5):1041-6. PubMed ID: 16225622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary cutaneous CD30+ anaplastic large cell lymphoma in a heart transplant patient: case report and literature review.
    Belloni-Fortina A; Montesco MC; Piaserico S; Bordignon M; Tona F; Feltrin G; Alaibac M
    Acta Derm Venereol; 2009; 89(1):74-7. PubMed ID: 19197546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signet ring cell primary cutaneous CD30+ lymphoproliferative disorder presenting as a monomorphic T-cell posttransplant lymphoproliferative disease.
    Papalas JA; Kulbacki EL; Park HK; Howell ER
    Am J Dermatopathol; 2012 Oct; 34(7):e94-6. PubMed ID: 22534639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Posttransplant lymphoproliferative disorder presenting as CD30+, ALK+, anaplastic large cell lymphoma in a child.
    Sebire NJ; Malone M; Ramsay AD
    Pediatr Dev Pathol; 2004; 7(3):290-3. PubMed ID: 15148593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquired ichthyosis associated with primary cutaneous CD30+ lymphoproliferative disorders.
    López Aventín D; Gallardo F; Yébenes M; Lloreta J; Pujol RM
    Eur J Dermatol; 2014; 24(1):105-6. PubMed ID: 24491290
    [No Abstract]   [Full Text] [Related]  

  • 6. Diagnostic and prognostic evaluation of phenotypic markers TRAF1, MUM1, BCL2 and CD15 in cutaneous CD30-positive lymphoproliferative disorders.
    Benner MF; Jansen PM; Meijer CJ; Willemze R
    Br J Dermatol; 2009 Jul; 161(1):121-7. PubMed ID: 19416236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD30+ lymphoproliferative disorders of the skin: still an open question.
    Alaibac M; Zarian H; Russo I; Peserico A
    G Ital Dermatol Venereol; 2012 Dec; 147(6):545-52. PubMed ID: 23149700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal pseudocarcinomatous hyperplasia with underlying epidermal growth factor-producing cutaneous CD30-positive lymphoproliferative disorder.
    Kawachi Y; Taguchi S; Fujisawa Y; Furuta J; Nakamura Y; Ishii Y; Takahashi T; Otsuka F
    J Eur Acad Dermatol Venereol; 2009 Feb; 23(2):181-3. PubMed ID: 18429982
    [No Abstract]   [Full Text] [Related]  

  • 9. Elevated serum immunoglobulin preceding primary cutaneous posttransplant lymphoproliferative disorder.
    Dabbs CR; Creel NB; Krivda SJ; Cruser DL; Norton SA
    J Am Acad Dermatol; 2005 May; 52(5 Suppl 1):S123-4. PubMed ID: 15858509
    [No Abstract]   [Full Text] [Related]  

  • 10. CD30-positive T-cell lymphoproliferative disorder of the oral mucosa--an indolent lesion: report of 4 cases.
    Agarwal M; Shenjere P; Blewitt RW; Hall G; Sloan P; Pigadas N; Banerjee SS
    Int J Surg Pathol; 2008 Jul; 16(3):286-90. PubMed ID: 18387994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD30(+) cutaneous lymphoproliferative disorders with pseudocarcinomatous hyperplasia are associated with a T-helper-17 cytokine profile and infiltrating granulocytes.
    Guitart J; Martinez-Escala ME; Deonizio JM; Gerami P; Kadin ME
    J Am Acad Dermatol; 2015 Mar; 72(3):508-15. PubMed ID: 25582534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary cutaneous T-cell lymphoma following organ transplantation in a 16-year-old boy.
    Amin A; Burkhart C; Groben P; Morrell DS
    Pediatr Dermatol; 2009; 26(1):112-3. PubMed ID: 19250431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Digestive and nutritional manifestations of Netherton's syndrome].
    Pradeaux L; Olives JP; Bonafé JL; Le Tallec C; Pigeon P; Ghisolfi J
    Arch Fr Pediatr; 1991 Feb; 48(2):95-8. PubMed ID: 2048952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skin lesions in adult liver transplant recipients: a study of 100 consecutive patients.
    Perera GK; Child FJ; Heaton N; O'Grady J; Higgins EM
    Br J Dermatol; 2006 May; 154(5):868-72. PubMed ID: 16634888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spontaneous regression of primary cutaneous Epstein-Barr virus-positive, CD30-positive anaplastic large T-cell lymphoma in a heart-transplant recipient.
    Chiu LS; Choi PC; Luk NM; Chang M; Tang WY
    Clin Exp Dermatol; 2009 Jul; 34(5):e21-4. PubMed ID: 19508468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD30+ lymphoproliferative disorders: histopathology, differential diagnosis, new variants, and simulators.
    Kempf W
    J Cutan Pathol; 2006 Feb; 33 Suppl 1():58-70. PubMed ID: 16412214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benign atypical intravascular CD30(+) T-cell proliferation: a reactive condition mimicking intravascular lymphoma.
    Riveiro-Falkenbach E; Fernández-Figueras MT; Rodríguez-Peralto JL
    Am J Dermatopathol; 2013 Apr; 35(2):143-50. PubMed ID: 23542715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular involvement by T-cell post-transplant lymphoproliferative disorder of cutaneous origin.
    Velankar MM; Kini AR
    Pathology; 2007 Jun; 39(3):369-71. PubMed ID: 17558871
    [No Abstract]   [Full Text] [Related]  

  • 19. MUM1 expression in cutaneous CD30+ lymphoproliferative disorders: a valuable tool for the distinction between lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma.
    Kempf W; Kutzner H; Cozzio A; Sander CA; Pfaltz MC; Müller B; Pfaltz M
    Br J Dermatol; 2008 Jun; 158(6):1280-7. PubMed ID: 18410414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of chemokines and chemokine receptors in cutaneous CD30+ lymphoproliferative disorders.
    Yamaguchi T; Ohshima K; Karube K; Kawano R; Nakayama J; Suzumiya J; Kikuchi M
    Br J Dermatol; 2006 May; 154(5):904-9. PubMed ID: 16634894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.